Minimal endometrial proliferation over a two-year period in postmenopausal women taking 0.3 mg of unopposed esterified estrogens

Menopause

Volumn 4, Issue 2, 1997, Pages 80-88

  Silfen, Sheryl L ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Endometrial hyperplasia; Hormone replacement therapy; Low dose estrogen; Menopause

Indexed keywords

EID: 27844495243     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199704020-00004     Document Type: Article

References (2)

1. Mack TM, Pike MC, Henderson BE, et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976;294:1262-7.
2. Grady D, Gebretsadik T, Kerikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-13.